All terms in GO

Label Id Description
superoxide-generating NADH oxidase activity. GO_0106291
Catalysis of the reaction: NADH + 2 O2 = H(+) + NAD(+) + 2 superoxide.
NADPH oxidase H202-forming activity GO_0106294
Catalysis of the reaction: NADPH + H+ + O2 = NADP + hydrogen peroxide (H2O2).
NADH oxidase H202-forming activity GO_0106293
Catalysis of the reaction: NADH + H+ + O2 = NAD + hydrogen peroxide (H2O2).
trans-cinnamate-CoA ligase activity GO_0106290
Catalysis of the reaction: (E)-cinnamate + ATP + CoA = (E)-cinnamoyl-CoA + AMP + diphosphate.
negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA GO_0106289
Any process that stops, prevents, or reduces the frequency, rate or extent of deadenylation-dependent decapping of nuclear-transcribed mRNA.
regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA GO_0106288
Any process that modulates the frequency, rate or extent of deadenylation-dependent decapping of nuclear-transcribed mRNA.
GO_0106287 GO_0106287
(E)-caffeate-CoA ligase activity GO_0106286
Catalysis of the reaction: (E)-caffeate + ATP + CoA = (E)-caffeoyl-CoA + AMP + diphosphate.
positive regulation of mitotic cytokinesis GO_1903490
Any process that activates or increases the frequency, rate or extent of mitotic cytokinesis.
regulation of mitotic cytokinesis GO_1902412
Any process that modulates the frequency, rate or extent of mitotic cytokinesis.
response to acetylsalicylate GO_1903492
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aspirin (acetylsalicylate) stimulus. Aspirin is a non-steroidal anti-inflammatory drug with moA cyclooxygenase inhibitor activity.
response to simvastatin GO_1903491
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a simvastatin stimulus. Simvastatin is a statin used as a cholesterol-lowering and anti-cardiovascular disease drug.
response to dehydroepiandrosterone GO_1903494
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dehydroepiandrosterone stimulus.
response to clopidogrel GO_1903493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a clopidogrel stimulus. Clopidogrel is a is an oral, thienopyridine-class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
response to 11-deoxycorticosterone GO_1903496
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 11-deoxycorticosterone stimulus.
cellular response to dehydroepiandrosterone GO_1903495
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dehydroepiandrosterone stimulus.
bundle sheath cell differentiation GO_1903498
The process in which a relatively unspecialized cell acquires the specialized features of a bundle sheath cell.
cellular response to 11-deoxycorticosterone GO_1903497
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 11-deoxycorticosterone stimulus.
regulation of mitotic actomyosin contractile ring assembly GO_1903499
Any process that modulates the frequency, rate or extent of mitotic actomyosin contractile ring assembly.
chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity GO_0106281
Catalysis of the reaction: chenodeoxycholate + NAD(+) = 7-oxolithocholate + H(+) + NADH.